The main therapeutic goal of GDNF-targeted approaches encompasses both neuroprotection in neurodegenerative disorders (e.g., PD) and the management of neuropathic conditions, in particular, sciatica and neuropathic pain of diverse etiologies. Here, GDNF is linked to Parkinson disease.